Komal Jhaveri, MD, clinical director for early drug development service at Memorial Sloan Kettering Cancer Center, and Saba Shaikh, MD, breast medical oncologist at Mays Cancer Center at UT Health San Antonio, discuss the DESTINY-Breast08 trial.
▷ Estimated Read Time:
1–2 minutes
SABCS Snippets: DESTINY-Breast08
Join the global breast cancer community for four days of research spanning experimental biology, etiology, translational science, prevention, diagnosis and treatment, December 8-11 in San Antonio, Texas.
Share: